APA

Guidi L., Costanzo M., Ciarniello M., De Vitis I., Pioli C., Gatta L., Pace L., Tricerri A., Bartoloni C., Coppola L., Balistreri P., Doria G., Fedeli G. & Gasbarrini G. B. (20050714). Increased levels of NF-kappaB inhibitors (IkappaBalpha and IkappaBgamma) in the intestinal mucosa of Crohn's disease patients during infliximab treatment. : International journal of immunopathology and pharmacology.

Chicago

Guidi L, Costanzo M, Ciarniello M, De Vitis I, Pioli C, Gatta L, Pace L, Tricerri A, Bartoloni C, Coppola L, Balistreri P, Doria G, Fedeli G and Gasbarrini G B. 20050714. Increased levels of NF-kappaB inhibitors (IkappaBalpha and IkappaBgamma) in the intestinal mucosa of Crohn's disease patients during infliximab treatment. : International journal of immunopathology and pharmacology.

Harvard

Guidi L., Costanzo M., Ciarniello M., De Vitis I., Pioli C., Gatta L., Pace L., Tricerri A., Bartoloni C., Coppola L., Balistreri P., Doria G., Fedeli G. and Gasbarrini G. B. (20050714). Increased levels of NF-kappaB inhibitors (IkappaBalpha and IkappaBgamma) in the intestinal mucosa of Crohn's disease patients during infliximab treatment. : International journal of immunopathology and pharmacology.

MLA

Guidi L, Costanzo M, Ciarniello M, De Vitis I, Pioli C, Gatta L, Pace L, Tricerri A, Bartoloni C, Coppola L, Balistreri P, Doria G, Fedeli G and Gasbarrini G B. Increased levels of NF-kappaB inhibitors (IkappaBalpha and IkappaBgamma) in the intestinal mucosa of Crohn's disease patients during infliximab treatment. : International journal of immunopathology and pharmacology. 20050714.